Dopamine for Animals

Dopamine

Dopamine is an endogenous catecholamine used as a short-acting intravenous vasoactive drug. Its veterinary role is hemodynamic support when inadequate cardiac output or vascular tone contributes to hypotension. The relative balance of dopaminergic, beta-adrenergic and alpha-adrenergic effects changes with exposure and the patient’s circulatory condition.

Group

Catecholamine inotrope and vasopressor

Mechanism of Action

Dopamine activates dopaminergic and adrenergic receptors and can increase norepinephrine release. D1-receptor stimulation relaxes some vascular beds, beta1 stimulation increases myocardial contractility and heart rate, and greater alpha1 activity increases vascular tone. These overlapping effects can raise cardiac output or arterial pressure. The response is not divided into rigid dose-specific receptor ranges and varies between species and patients.

Dose Rates

Dog

Use / stageDoseRouteScheduleInstructions
Cardiovascular support2–10 mcg/kg/minIVContinuous
Low-dose vasodilation0.5–2 mcg/kg/minIVContinuousPharmacologic range; not evidence of effective treatment for acute kidney injury.

Cat

Use / stageDoseRouteScheduleInstructions
Cardiovascular support2–10 mcg/kg/minIVContinuous
Low-dose vasodilation0.5–2 mcg/kg/minIVContinuousPharmacologic range; not evidence of effective treatment for acute kidney injury.

Horse

Use / stageDoseRouteScheduleInstructions
Cardiovascular support1–5 mcg/kg/minIVContinuous

Cattle

Use / stageDoseRouteScheduleInstructions
Cardiovascular support1–5 mcg/kg/minIVContinuous

Indications

  • Vasoactive support for persistent hypotension in selected veterinary patients with circulatory shock after appropriate restoration of circulating volume.
  • Short-term support of cardiac output and arterial pressure in selected patients with acute cardiac failure or myocardial dysfunction.
  • Cardiovascular support during anesthesia when a combined inotropic and vasopressor effect is clinically indicated.

Contraindications

  • Use controlled infusion with cardiovascular monitoring.

Interactions

  • Incompatible with alkaline/bicarbonate solutions.

Adverse effects

  • Tachycardia and ventricular arrhythmias

Preparations

PreparationFormStrengthRoute
Dopamine concentrate 40 mg/mL
Must be diluted for controlled infusion.
Injection40 mg / mLIV
Dopamine concentrate 80 mg/mL
Must be diluted for controlled infusion.
Injection80 mg / mLIV
Dopamine concentrate 160 mg/mL
Must be diluted for controlled infusion.
Injection160 mg / mLIV

Monitoring and Administration

Monitor ECG, blood pressure and perfusion; titrate to response. Renal-protective benefit is not established, and feline renal dopaminergic response is limited.

Diluted solution in compatible fluids has a reported 24-hour stability; discard brown or purple solution.

Rates above 10 mcg/kg/min produce stronger alpha-mediated vasoconstriction; the source supplies no bounded upper range.

Scroll to Top